Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Acquisition

11 Apr 2017 15:30

RNS Number : 2115C
Exova Group PLC
11 April 2017
Β 

Β 

STOCK EXCHANGE RELEASE

Β 

11 April 2017

Exova Group plc

Β 

Exova acquires SL Pharma Labs Incorporated

Β 

Exova Group plc ("Exova") EXO.L, the global testing, calibration and advisory services provider, has acquired SL Pharma Labs Incorporated (SL Pharma), a Delaware, US, based business that provides laboratory and clinical manufacture testing services to pharmaceutical, biotechnology and medical device companies.

Founded in 1997, SL Pharma has built a strong reputation in the provision of high value and high quality pharmaceutical product development and testing services focused primarily on the development and clinical manufacture of parenteral, ophthalmic, intranasal and topical drug products. The business has a team of 14 specialists and achieved revenues of around $2.5m in 2016.

Ian El-Mokadem, Chief Executive Officer at Exova, said: "This acquisition complements our existing operations by enhancing Exova's technical expertise in pharmaceutical services and offers a great foundation for further growth in North America. SL Pharma's addition to our portfolio clearly demonstrates our commitment to providing more technically demanding services and developing our capabilities in new markets."

Β 

ENDS

Β 

Β 

Enquiries:

Β 

Andy Jones

Powerscourt

T: +44 (0) 20 7549 0747

E: andy.jones@exova.com

Β 

Andrew Pickup

Corporate Affairs Director, Exova Group plc

T: +44 (0) 7920 243 393

E: andrew.pickup@exova.com

Exova

Β 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 135 laboratories and offices in 33 countries and employs around 4,200 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Transportation; and Health Sciences.

Exova Group plc is registered in England (registration number 08907086). Its legal entity identifier ('LEI') number is 213800BFE317FGSYMZ19.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQBBGDSSGBBGRB
Date   Source Headline
19th Dec 20143:30 pmRNSDirector/PDMR Shareholding
16th Dec 20144:40 pmRNSSecond Price Monitoring Extn
16th Dec 20144:35 pmRNSPrice Monitoring Extension
12th Dec 20144:40 pmRNSSecond Price Monitoring Extn
12th Dec 20144:35 pmRNSPrice Monitoring Extension
10th Dec 201410:00 amRNSManagement Change
20th Nov 20143:40 pmRNSDirector/PDMR Shareholding
19th Nov 20144:30 pmRNSTR-1: Notification of Major Interest in Shares
19th Nov 20147:00 amRNSTrading Update
4th Nov 20144:40 pmRNSSecond Price Monitoring Extn
4th Nov 20144:35 pmRNSPrice Monitoring Extension
30th Oct 20144:35 pmRNSPrice Monitoring Extension
27th Oct 20144:40 pmRNSSecond Price Monitoring Extn
27th Oct 20144:35 pmRNSPrice Monitoring Extension
21st Oct 20143:11 pmRNSTR-1: Notification of Major Interest in Shares
17th Oct 20144:40 pmRNSSecond Price Monitoring Extn
17th Oct 20144:35 pmRNSPrice Monitoring Extension
13th Oct 20144:35 pmRNSPrice Monitoring Extension
3rd Oct 20149:40 amRNSHolding(s) in Company
1st Oct 20143:30 pmRNSTotal Voting Rights
30th Sep 20149:26 amRNSNotification of transaction of PDMRs
11th Sep 20149:10 amRNSHolding(s) in Company
4th Sep 20145:15 pmRNSIssue of Equity
4th Sep 201411:10 amRNSDirector/PDMR Shareholding
3rd Sep 20141:45 pmRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNS2014 Half Year Results
21st Jul 20148:00 amRNSAcquisition
30th Jun 20147:00 amRNSAnalyst Site Visit
3rd Jun 201410:08 amRNSDirector/PDMR Shareholding
3rd Jun 201410:03 amRNSAppointment of Joint Corporate Brokers
28th May 201411:18 amRNSNotification of new directorship
19th May 20147:00 amRNSInterim Management Statement
15th May 20141:52 pmRNSTR-1: Notification of major interest in shares
12th May 20144:14 pmRNSTR-1: Notification of major interest in shares
9th May 20145:00 pmRNSExova Group PLC - End of Stabilisation Notice
9th May 20144:54 pmRNSExercise of Over-allotment Option
28th Apr 20143:15 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20149:30 amRNSDirector/PDMR Shareholding
22nd Apr 20149:30 amRNSTR-1: Notification of major interest in shares
22nd Apr 20149:30 amRNSTR-1: Notification of major interest in shares
16th Apr 20148:24 amRNSDirector Declaration
16th Apr 20148:01 amRNSAdmission to Listing on LSE
11th Apr 201412:27 pmRNSPublication of Prospectus
11th Apr 20147:01 amRNSStabilisation Notice
11th Apr 20147:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.